Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology Annual Meeting Life Science Investing
Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual Meeting Life Science Investing
Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults Pharmaceutical Investing
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference Life Science Investing
Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase Life Science Investing
Sona Nanotech Touts "Superior" Results from Animal Study for Cancer Therapy, Eyes In-human Study Nanotech Investing
Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024 Life Science Investing
MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting Life Science Investing
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024 Life Science Investing
